Photo from wikipedia
Dupilumab is a human monoclonal IgG4 antibody that inhibits IL-4 and IL-13 signalling by binding specifically to the IL-4Rα subunit, shared by both the IL4 and IL-13 receptor complexes (1)… Click to show full abstract
Dupilumab is a human monoclonal IgG4 antibody that inhibits IL-4 and IL-13 signalling by binding specifically to the IL-4Rα subunit, shared by both the IL4 and IL-13 receptor complexes (1) recently introduced for the treatment of severe atopic dermatitis (AD). We report a case of severe AD associated with cold urticaria that healed shortly after starting Dupilumab therapy. This article is protected by copyright. All rights reserved.
Keywords:
severe atopic;
treatment;
cold urticaria;
atopic dermatitis
Journal Title: Clinical and Experimental Dermatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical and Experimental Dermatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!